Invention Grant
- Patent Title: Anti-ErbB3 antibodies
-
Application No.: US14987374Application Date: 2016-01-04
-
Publication No.: US09598498B2Publication Date: 2017-03-21
- Inventor: Sylvie Vincent , William M. Winston, Jr. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Bottega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
- Applicant: AVEO Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: AVEO Pharmaceuticals, Inc.
- Current Assignee: AVEO Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Goodwin Procter LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/32 ; C07K16/30 ; A61K39/00
Abstract:
Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
Public/Granted literature
- US20160264679A1 ANTI-ERBB3 ANTIBODIES Public/Granted day:2016-09-15
Information query
